These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22159923)

  • 21. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization.
    Jarabek AM; Pottenger LH; Andrews LS; Casciano D; Embry MR; Kim JH; Preston RJ; Reddy MV; Schoeny R; Shuker D; Skare J; Swenberg J; Williams GM; Zeiger E
    Crit Rev Toxicol; 2009; 39(8):659-78. PubMed ID: 19743944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomonitoring: is body burden relevant to public health?
    Paustenbach D; Galbraith D
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):249-61. PubMed ID: 16473444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of biomarkers in population studies: from exposure to susceptibility and to prediction of cancer.
    Au WW
    Int J Hyg Environ Health; 2007 May; 210(3-4):239-46. PubMed ID: 17174154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating lifetime risk from spot biomarker data and intraclass correlation coefficients (ICC).
    Pleil JD; Sobus JR
    J Toxicol Environ Health A; 2013; 76(12):747-66. PubMed ID: 23980840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human exposure assessment to environmental chemicals using biomonitoring.
    Calafat AM; Ye X; Silva MJ; Kuklenyik Z; Needham LL
    Int J Androl; 2006 Feb; 29(1):166-71; discussion 181-5. PubMed ID: 16466536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers of susceptibility to chemical carcinogens: the example of non-Hodgkin lymphomas.
    Kelly RS; Vineis P
    Br Med Bull; 2014 Sep; 111(1):89-100. PubMed ID: 25114269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomonitoring Equivalents (BE) dossier for trihalomethanes.
    Aylward LL; LaKind JS; Hays SM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3 Suppl):S68-77. PubMed ID: 18579267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human biomonitoring: political benefits--scientific challenges. September 26-28, 2010.
    Kolossa-Gehring M
    Int J Hyg Environ Health; 2012 Feb; 215(2):247-52. PubMed ID: 22169170
    [No Abstract]   [Full Text] [Related]  

  • 30. Banding carcinogenic risks in developed countries: A procedural basis for qualitative assessment.
    Stewart BW
    Mutat Res; 2008; 658(1-2):124-151. PubMed ID: 18357634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical surveillance and biomonitoring for occupational cancer endpoints.
    Cone JE; Rosenberg J
    Occup Med; 1990; 5(3):563-81. PubMed ID: 2218803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer and the environment: Ten topics in environmental cancer epidemiology in Canada.
    Huchcroft SA; Mao Y; Semenciw R
    Chronic Dis Can; 2010; 29 Suppl 1():1-35. PubMed ID: 21199597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk.
    Wild CP; Scalbert A; Herceg Z
    Environ Mol Mutagen; 2013 Aug; 54(7):480-99. PubMed ID: 23681765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human biomonitoring activities--programmes by industry.
    Boogaard PJ
    Int J Hyg Environ Health; 2007 May; 210(3-4):259-61. PubMed ID: 17275410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of inherited susceptibility and cancer.
    Rebbeck TR
    IARC Sci Publ; 2004; (157):91-103. PubMed ID: 15055292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotoxicity of environmental agents assessed by the alkaline comet assay.
    Møller P
    Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of non-genotoxic carcinogenesis in rats using changes in gene expression following acute dosing.
    Nioi P; Pardo ID; Sherratt PJ; Snyder RD
    Chem Biol Interact; 2008 Apr; 172(3):206-15. PubMed ID: 18328469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A weight of evidence approach for selecting exposure biomarkers for biomonitoring.
    Zelenka MP; Barr DB; Nicolich MJ; Lewis RJ; Bird MG; Letinski DJ; Metcalf SW; O'Lone RB
    Biomarkers; 2011 Feb; 16(1):65-73. PubMed ID: 21250852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenge assay: A functional biomarker for exposure-induced DNA repair deficiency and for risk of cancer.
    Au WW; Giri AK; Ruchirawat M
    Int J Hyg Environ Health; 2010 Jan; 213(1):32-9. PubMed ID: 19818682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.